# Big Data and Genomic Imaging for the Development of Biomarkers and Nanovector Drugs Innovative for Diagnosis and Therapy of Inflammatory Processes in Dementia

> **NCT05761535** · — · COMPLETED · sponsor: **IRCCS SYNLAB SDN** · enrollment: 137 (actual)

## Conditions studied

- Neurodegenerative Diseases

## Interventions

- **RADIATION:** Magnetic Resonance (MR) and positron emission tomograph (PET) imaging analyses

## Key facts

- **NCT ID:** NCT05761535
- **Lead sponsor:** IRCCS SYNLAB SDN
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-17
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-06-30
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05761535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05761535, "Big Data and Genomic Imaging for the Development of Biomarkers and Nanovector Drugs Innovative for Diagnosis and Therapy of Inflammatory Processes in Dementia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05761535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*